FDA Approves First Gene Therapies for Sickle Cell Disease
U.S. Food and Drug Administration
The FDA granted the approval of Casgevy to Vertex Pharmaceuticals Inc., and Lyfgenia to Bluebird Bio Inc.
Hematology
Introducing Today's Clinical Lab 2024 All Inclusive Pass
Today's Clinical Lab
Sign up for all of our 2024 digital events with one click
2024 Blood & Clinical Chemistry Digital Forum
Today's Clinical Lab
Join Today's Clinical Lab and our experts for our Blood & Clinical Chemistry Digital Forum on September 26, 2024
FDA Approves Recombinant Enzyme to Treat Rare Blood Clotting Disorder
U.S. Food and Drug Administration
Adzynma safely and effectively “filled in” for the mutated ADAMTS13 enzyme in patients with cTTP
FDA Approves New Therapeutic for Myelodysplastic Syndromes
U.S. Food and Drug Administration
Tibsovo can be used with FDA-approved companion diagnostic RealTime IDH1 Assay to detect and treat MDS
New Transfusion Guidelines Recommend Assessing Patient Comorbidities
Rutgers University
The expert panel developed recommendations to conserve blood supply and prevent transfusion-related illnesses
Small-Volume Blood Draws Could Cut Down Transfusions
The Ottawa Hospital
The large trial showed switching to smaller collection tubes saved almost one blood transfusion for every 10 patients
Reduce Risk and Reap Rewards with Automated Phase Separation
Tecan
Automated phase separation eliminates common pitfalls of traditional blood separation techniques
Epigenetic Changes as Blood Cancer Therapeutic Targets
National University of Singapore
Scientists seek to exploit cancer development pathway vulnerabilities to personalize high-risk myeloma treatments
New Gene Therapy for Sickle Cell Disease Shows Promise in Trials
University of Chicago Medical Center
Trial findings add to growing body of evidence supporting CRISPR-Cas9-led gene therapies for genetic diseases
AI-Driven Tool Reliably Diagnoses Blood Disorders
DKFZ German Cancer Research Center
Trained on patient data, the open-source algorithm can aid hematological diagnoses and even genetic analyses
'Improving Diagnostics Improves Care'
Miriam Bergeret, MSc
The Today's Clinical Lab June 2023 Blood and Microbiology issue features emerging technology and diagnostics
Molecular Testing in the Transfusion Medicine Laboratory
Maria Roussakis, MLT, MSc
Applying molecular techniques to transfusion medicine can help improve care for all
August 2023: Blood & Microbiology Digital Forum
Today's Clinical Lab
Join Today's Clinical Lab and our speakers at our virtual Blood & Microbiology Digital Forum on August 23, 2023
Pharmacoscopy: Novel Screening Method for Multiple Myeloma
ETH Zurich
Automated screening helps identify and test hundreds of new, effective, customized treatment options
FDA Approves Posttransplant Cell Therapy for Patients with Blood Cancers
U.S. Food and Drug Administration
Omisirge treatment hastens WBC recovery and reduces posttransplant disease risk but may cause adverse effects
Glycans in Blood May Predict Alzheimer’s Disease
Karolinska Institutet
Patients with matching levels of certain blood glycans and tau protein were over twice as likely to develop Alzheimer’s
Urine, Blood Biomarkers to Predict CKD Progression
Johns Hopkins Medicine
Researchers identify biomarkers to predict chronic kidney disease risk in hospitalized patients with acute kidney injury
Novel Point-of-Care, Finger-Prick Test for Trichomoniasis
Washington State University
Test helps curb common STI, gives results in five minutes, and may cost about $20
First-Ever FISH Probes for Patient Management Granted IVDR Certification
Oxford Gene Technology
IVDR-compliant products help boost patient safety as well as future-proof customer supply chains